Eurogin is part of the Informa Markets Division of Informa PLC

Informa
Informa

EUROGIN 2023 abstract submission deadline extended! New submission deadline: October 17

EUROGIN 2023

HPV and Head & Neck Forum

Coordinators: E. Rettig (USA), K. Lang Kuhs (USA),
J. Klussmann (Germany), H. Mirghani (France)

The EUROGIN HPV and Head & Neck Cancer Forum highlights recent advances and areas of active research in the field of HPV-related head and neck cancers. This year’s Forum features talks on epidemiology and prevention, HPV-OPC screening studies, updates on current management, innovations in surveillance and new discoveries of the molecular landscape of HPV-OPC tumors. New for this year, the Forum will also feature several panel discussions exploring the potential promise and peril of screening, surgery versus chemoradiation therapy and risks versus benefit of using liquid biopsy for HPV-OPC surveillance.

Epidemiology and Prevention of HPV-OPC

Chair: E. Rettig (USA)

  • Epidemiologic Updates in HPV-OPC
  • HPV-OPC Incidence trends
  • Oral HPV Infection and HIV
  • Impact of Tonsillectomy on Risk of HPV-OPC
  • HPV Vaccination for Prevention of Oral HPV Infection
  • Patient and Partner Questions and Answers

Screening for HPV-OPC

Chair: T. Waterboer (Germany), K. Lang Kuhs (USA)

  • Voyager, HIV endeavour Trial Updates
  • MOUTH Trial Updates
  • Biomarker-Based Screening Trial Updates
  • Modelling Serologic Screening for HPV-OPC
  • Prediagnostic Liquid Biopsy
  • PANEL: Pros vs Cons of Screening for HPV-OPC

Management

Chair: H. Mirghani (France)

  • Outcome Beyond Survival
  • Adjuvant Radiation Reduction After Surgery for HPV-OPC
  • ORATOR Trials
  • Definitive Radiation Reduction
  • Neoadjuvant Immunotherapy pre-CRT in HPV-OPC
  • PANEL: Surgery versus CRT for HPV-OPC

Molecular Diagnosis and Surveillance

Chair: P. Klussmann (Germany)

  • Prognostic implication of p16/HPV discordance
  • Cell-free HPV DNA in Urine
  • TTMV-HPV DNA for Surveillance in the Clinic
  • Liquid Biopsy Techniques
  • Randomized Controlled Trial of Standard vs Liquid Biopsy-Based Surveillance
  • PANEL: Pros vs Cons of Liquid Biopsy for Surveillance

Basic science

Chair: S. Virani (USA)

  • Recurrent Respiratory Papillomatosis: Updates
  • HPV Therapeutic Vaccine Trials
  • Tumor-Infiltrating Lymphocytes and Risk Stratification in HPV-OPC
  • Single Cell Sequencing in HPV-OPC
  • Granular stratification of OPC patients Using Standard H&E Staining
  • Evaluation of HPV Genome Integration